Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?

Leuk Lymphoma. 2020 Sep;61(9):2031-2033. doi: 10.1080/10428194.2020.1795164. Epub 2020 Jul 30.

Authors

Carrie van der Weyden¹, Sean Harrop^{1

2}, Henry Miles Prince^{1

2

3

4}

Affiliations

¹ Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
² Epworth Healthcare, Melbourne, Australia.
³ Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
⁴ Monash University, Melbourne, Australia.

PMID: 32729765
DOI: 10.1080/10428194.2020.1795164

No abstract available

Publication types

Comment

MeSH terms

Aminopterin / adverse effects
Aminopterin / analogs & derivatives
Humans
Immunoblastic Lymphadenopathy* / diagnosis
Immunoblastic Lymphadenopathy* / drug therapy
Lymphoma, T-Cell* / diagnosis
Lymphoma, T-Cell* / drug therapy

Substances

10-propargyl-10-deazaaminopterin
Aminopterin